43
Participants
Start Date
December 31, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
AB103
AB103 0.25 mg/kg or 0.5 mg/kg administered as a single IV infusion
Placebo
Normal saline (0.9% sodium chloride) administered as a single IV infusion
University of Pittsburgh Medical Center, Pittsburgh
University of Maryland Medical Center, Baltimore
Harborview Medical Center, Seattle
University of Southern California Los Angeles, Los Angeles
San Francisco General Hospital, San Francisco
University of Florida, Gainesville
Oregon Health and Science University, Portland
Lead Sponsor
Atox Bio Ltd
INDUSTRY